Financhill
Buy
68

TARS Quote, Financials, Valuation and Earnings

Last price:
$81.77
Seasonality move :
24.87%
Day range:
$80.65 - $82.23
52-week range:
$38.51 - $83.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.09x
P/B ratio:
10.36x
Volume:
249.6K
Avg. volume:
442.9K
1-year change:
62.5%
Market cap:
$3.5B
Revenue:
$183M
EPS (TTM):
-$2.01

Earnings Data

Next earnings date for TARS
Feb 25
2026
Most recent earnings per share
-$0.30
Beat by $0.03
(Nov 4/2025)
Consensus Estimate
-$0.33
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TARS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $143.8M -- -- -$0.01 --
11/04/2025 Q3 $115.2M $118.7M -$0.30 -$0.33 $0.03
08/06/2025 Q2 $95.8M $102.7M -$0.48 -$0.36 -$0.12
05/01/2025 Q1 $72.5M $78.3M -$0.64 -$0.63 -$0.01
02/25/2025 Q4 $58.8M $66.4M -$0.60 -$0.78 $0.18
11/13/2024 Q3 $43.2M $48.1M -$0.61 -$1.00 $0.39
08/08/2024 Q2 $32M $40.8M -$0.88 -$0.80 -$0.08
05/08/2024 Q1 $17.9M $27.6M -$1.01 -$1.25 $0.24
02/27/2024 Q4 $5.9M $13.1M -$1.31 -$1.49 $0.18
11/09/2023 Q3 $361K $1.9M -$1.28 -$1.27 -$0.01
08/10/2023 Q2 -- -- -$1.17 -- --
05/09/2023 Q1 -- $2.5M -$0.88 -- --
03/13/2023 Q4 -- $10M -$0.51 -- --
11/09/2022 Q3 -- -- -$0.84 -- --
08/11/2022 Q2 -- $15.3M -$0.24 -- --
05/10/2022 Q1 -- $539K -$0.98 -- --
03/14/2022 Q4 -- $338K -$0.72 -- --
11/09/2021 Q3 -- $1.2M -$0.76 -- --
08/04/2021 Q2 -- $22M $0.29 -- --
05/11/2021 Q1 -- $33.4M $0.47 -- --
03/31/2021 Q4 -- -- -$0.56 -- --
11/25/2020 Q3 -- -- -$0.50 -- --
06/30/2020 Q2 -- -- -$0.30 -- --
03/31/2020 Q1 -- -- -$0.10 -- --
12/31/2019 Q4 -- -- -$0.13 -- --
09/30/2019 Q3 -- -- -$0.03 -- --

Tarsus Pharmaceuticals, Inc. Earnings Questions

  • How Much did Tarsus Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Tarsus Pharmaceuticals, Inc. reported $118.7M worth of top line sales in its most recent quarter.

  • Did Tarsus Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Tarsus Pharmaceuticals, Inc. announced earnings per share of -$0.30 which represents a beat of analyst forecast a -$0.33 per share.

  • Is Tarsus Pharmaceuticals, Inc. Profitable?

    Tarsus Pharmaceuticals, Inc. reported $110.4M that represents $2.59 per share over the last quarter.

  • What is the Analyst Consensus for Tarsus Pharmaceuticals, Inc. EPS Next Year?

    Tarsus Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$3.07 per share to -$3.09 per share next year representing a decrease of -53.73%.

  • When is Tarsus Pharmaceuticals, Inc.'s Earnings Date?

    Tarsus Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock